CN Patent

CN111344287B — 作为吲哚胺2，3-双加氧酶(ido)抑制剂的新型取代的联芳基化合物

Assigned to Merck Sharp and Dohme BV · Expires 2023-12-19 · 2y expired

What this patent protects

本文公开了一种式(I)的化合物或其药学上可接受的盐。本文还公开了本文公开的化合物在与IDO相关的疾病或病症的潜在治疗或预防中的用途。本文还公开了包含本文公开的化合物的组合物。本文进一步公开了组合物在与IDO相关的疾病或病症的潜在治疗或预防中用途。

USPTO Abstract

本文公开了一种式(I)的化合物或其药学上可接受的盐。本文还公开了本文公开的化合物在与IDO相关的疾病或病症的潜在治疗或预防中的用途。本文还公开了包含本文公开的化合物的组合物。本文进一步公开了组合物在与IDO相关的疾病或病症的潜在治疗或预防中用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN111344287B
Jurisdiction: CN
Classification: —
Expires: 2023-12-19
Drug substance claim: No
Drug product claim: No
Assignee: Merck Sharp and Dohme BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.